Harriet Wright1, Ayman S Bannaga1,2, Rolland Iriarte2, Mshail Mahmoud3, Ramesh P Arasaradnam4,5,6,7. 1. Warwick Medical School, Warwick University, Coventry, UK. 2. University Hospital Coventry & Warwickshire, Coventry, UK. 3. Heartlands Hospital, Birmingham, UK. 4. Warwick Medical School, Warwick University, Coventry, UK. r.arasaradnam@warwick.ac.uk. 5. University Hospital Coventry & Warwickshire, Coventry, UK. r.arasaradnam@warwick.ac.uk. 6. Applied Health Sciences, University of Coventry, Coventry, UK. r.arasaradnam@warwick.ac.uk. 7. School of Health Sciences, University of Leicester, Leicester, UK. r.arasaradnam@warwick.ac.uk.
Abstract
BACKGROUND: Volatile organic compounds (VOCs) are hydrocarbons that originate within different healthy and diseased tissues. VOCs can be secreted into the circulation and then excreted in the urine and faeces. In the lungs, VOCs are locally produced and can be detected in exhaled breath. VOCs can be identified using non-invasive techniques, which make their use in preterm infants safe and desirable. METHODS: A systematic search of the literature in PubMed, Embase and Web of Science was conducted looking for VOCs techniques and diagnostic performance in preterm infants. A total of 50 articles identified with only seven papers were included in the final analysis in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). RESULTS: VOCs could diagnose necrotising enterocolitis up to 4 days before a clinical diagnosis; for late onset sepsis, up to 3 days before; and for bronchopulmonary dysplasia, up to 2 weeks before. In addition to these diagnostic uses, VOCs analysis could also distinguish breastfed from formula-fed preterm neonates in the first month of life. CONCLUSION: VOCs analysis is a non-invasive tool that makes the use in preterm infants of preference. VOCs analytic techniques require more research and consensus between researchers to overcome their limitations. IMPACT: Volatile organic compounds are hydrocarbons that can separate between healthy and diseased states in preterm infants. Biomarker panels developed from volatile organic compounds are potential diagnostic tools. The non-invasive nature of acquiring volatile organic compounds markers make it desirable in the paediatric patients. Research into exact chemical components of the volatile organic compounds can inform about the pathophysiology of disease in preterm infants. More robust longitudinal studies with repeated experiments are required before volatile organic compounds can be applied in clinical practice.
BACKGROUND: Volatile organic compounds (VOCs) are hydrocarbons that originate within different healthy and diseased tissues. VOCs can be secreted into the circulation and then excreted in the urine and faeces. In the lungs, VOCs are locally produced and can be detected in exhaled breath. VOCs can be identified using non-invasive techniques, which make their use in preterm infants safe and desirable. METHODS: A systematic search of the literature in PubMed, Embase and Web of Science was conducted looking for VOCs techniques and diagnostic performance in preterm infants. A total of 50 articles identified with only seven papers were included in the final analysis in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). RESULTS: VOCs could diagnose necrotising enterocolitis up to 4 days before a clinical diagnosis; for late onset sepsis, up to 3 days before; and for bronchopulmonary dysplasia, up to 2 weeks before. In addition to these diagnostic uses, VOCs analysis could also distinguish breastfed from formula-fed preterm neonates in the first month of life. CONCLUSION: VOCs analysis is a non-invasive tool that makes the use in preterm infants of preference. VOCs analytic techniques require more research and consensus between researchers to overcome their limitations. IMPACT: Volatile organic compounds are hydrocarbons that can separate between healthy and diseased states in preterm infants. Biomarker panels developed from volatile organic compounds are potential diagnostic tools. The non-invasive nature of acquiring volatile organic compounds markers make it desirable in the paediatric patients. Research into exact chemical components of the volatile organic compounds can inform about the pathophysiology of disease in preterm infants. More robust longitudinal studies with repeated experiments are required before volatile organic compounds can be applied in clinical practice.
Authors: Daniel J C Berkhout; Britt J van Keulen; Hendrik J Niemarkt; Jet R Bessem; Willem P de Boode; Veerle Cossey; Neil Hoogenes; Christiaan V Hulzebos; Ellen Klaver; Peter Andriessen; Anton H van Kaam; Boris W Kramer; Richard A van Lingen; Aaron Schouten; Johannes B van Goudoever; Daniel C Vijlbrief; Mirjam M van Weissenbruch; Alfian N Wicaksono; James A Covington; Marc A Benninga; Nanne K H de Boer; Tim G J de Meij Journal: Clin Infect Dis Date: 2019-01-01 Impact factor: 9.079
Authors: Ana Carolina Pádua; Susana Palma; Jonas Gruber; Hugo Gamboa; Ana Cecília Roque Journal: Biomed Eng Syst Technol Int Jt Conf BIOSTEC Revis Sel Pap Date: 2018
Authors: Christopher Bradley; Siew Wan Hee; Lazaros Andronis; Krishna Persaud; Mark A Hull; John Todd; Sian Taylor-Phillips; Steve Smith; Rachel Constable; Norman Waugh; Ramesh P Arasaradnam Journal: BMJ Open Date: 2022-03-30 Impact factor: 2.692